Table 2.
Univariate analyses |
Multivariate analyses* |
|||
---|---|---|---|---|
Variables | HR (95%CI) | P value | HR (95%CI) | P value |
ABL1 | 2.36 (1.47–3.81) | <0.001 | 2.44 (1.40–4.27) | 0.001 |
ATF2 | 2.11 (1.24–3.61) | 0.006 | 1.18 (0.61–2.26) | 0.626 |
ATG5 | 1.65 (1.03–2.62) | 0.035 | 1.06 (0.62–1.79) | 0.842 |
C6 | 1.59 (1.00–2.53) | 0.049 | 1.34 (0.77–2.35) | 0.301 |
CD38 | 0.50 (0.31–0.80) | 0.003 | 0.42 (0.25–0.68) | <0.001 |
ICOSLG | 2.01 (1.15–3.50) | 0.014 | 2.01 (1.09–3.71) | 0.025 |
IL12RB2 | 0.62 (0.39–0.98) | 0.039 | 0.65 (0.38–1.10) | 0.107 |
HMGB1 | 1.99 (1.25–3.17) | 0.003 | 1.50 (0.87–2.60) | 0.145 |
PLAU | 1.71 (1.08–2.74) | 0.023 | 1.57 (0.91–2.69) | 0.101 |
N stage | 2.21 (1.35–3.62) | 0.002 | 1.51 (0.87–2.61) | 0.143 |
Factors included in the multivariate model were nine prognostic genes and N stage in the univariate analysis listed by the left.